Photo of Yulin Li

View Scopus Profile

Yulin Li, MD, PhD

  • 1323 Citations
  • 10 h-Index
20032020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Dr. Li finished his medical school at Beijing Medical University and his graduate school at Penn State. He had his postdoctoral training at Stanford University before joining the Research Institute in late 2017.

Research interests

Dr. Li's research interests includes 1) Roles of oncogenes in tumorigenesis, and 2) Rational combination therapy.  Dr. Li's lab utilizes both experimental and computational approaches to study cancer and rare diseases.

Research Area Keywords

  • Cancer

Free-text keywords

  • Combination therapy
  • Differentiation
  • Proteomics in oncology

Fingerprint Dive into the research topics where Yulin Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Rational Combination Therapy for Aggressive Double-Hit Lymphoma

Li, Y.

8/31/20 → 8/30/23

Project: State

The Role of Suv420h1 Histone Methyltransferase in MYC-Driven Tumorigenesis

Li, Y.

9/8/17 → 8/31/21

Project: Federal Funding Agencies

Research Output

  • 1323 Citations
  • 10 h-Index
  • 15 Article
  • 3 Review article
  • 2 Editorial

XPO1-dependent nuclear export as a target for cancer therapy

Azizian, N. G., Azizian, N. G., Li, Y. & Li, Y., Jun 1 2020, In : Journal of Hematology and Oncology. 13, 1, 61.

Research output: Contribution to journal › Review article

    • Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index

    Li, Y., Thomas, D., Deutzmann, A., Majeti, R., Felsher, D. W. & Dill, D. L., Nov 14 2019, In : Scientific Reports. 9, 1, p. 16775

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma

    Liu, Y., Azizian, N. G., Dou, Y., Pham, L. V. & Li, Y., Nov 21 2019, In : Journal of Hematology and Oncology. 12, 1

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    BIM-mediated apoptosis and oncogene addiction

    Li, Y., Deutzmann, A. & Felsher, D. W., Sep 29 2016, In : Aging. 8, 9, p. 1834-1835 2 p.

    Research output: Contribution to journal › Editorial

    1 Scopus citations

    BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia

    Li, Y., Deutzmann, A., Choi, P. S., Fan, A. C. & Felsher, D. W., May 10 2016, In : Oncotarget. 7, 19, p. 26926-26934 9 p.

    Research output: Contribution to journal › Article

    • 8 Scopus citations